CLINICAL_TRIALS
trial_result
· 2009-09-25
Clinical Trial Update: Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia [Phase 2]
Summary
Phase II trial evaluating AS1411 in combination with cytarabine for acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Antisoma Research | Conditions: Leukemia, Myeloid | Phase 2 | Status: COMPLETED